recover initiative

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00541-8/fulltext Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents Qiong Wu Bingyu Zhang Jiayi Tong L. Charles Bailey H. Timothy Bunnell Jiajie Chen b,c ∙ et al...

Abstract: Background Shared symptoms and biological abnormalities between post-acute sequelae of SARS-CoV-2 infection (PASC) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) could suggest common pathophysiological bases and would support coordinated treatment efforts. Empirical...

Reinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort Study Bingyu Zhang; Qiong Wu; Ravi Jhaveri; Ting Zhou; Michael J. Becich; Yuriy Bisyuk; Frank Blanceró; Elizabeth A. Chrischilles; Cynthia H...

Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19 Dazheng Zhang et 84 al. for the Researching COVID to Enhance Recovery (RECOVER) Initiative IMPORTANCE The profile of gastrointestinal (GI) tract outcomes associated with the postacute and chronic phases of COVID-19...

Long-COVID incidence proportion in adults and children between 2020 and 2024 Mandel, Hannah; Yoo, Yun J; Allen, Andrea J; Abedian, Sajjad; Verzani, Zoe; Karlson, Elizabeth W; Kleinman, Lawrence C; Mudumbi, Praveen C; Oliveira, Carlos R; Muszynski, Jennifer A; Gross, Rachel S; Carton, Thomas W...

Sex Differences in Long COVID Dimpy P. Shah et 1226 al. IMPORTANCE A substantial number of individuals worldwide experience long COVID, or post-COVID condition. Other postviral and autoimmune conditions have a female predominance, but whether the same is true for long COVID, especially within...

Methodologic and Policy Efforts to Improve a National Long COVID Study Jason, Leonard A. Researching COVID to Enhance Recovery (RECOVER) is a National Institutes of Health initiative to improve our understanding of recovery after SARS-CoV-2 infection and to prevent and treat Long COVID. For...

A multi-omics strategy to understand PASC through the RECOVER cohorts: a paradigm for a systems biology approach to the study of chronic conditions Sun, Jun; Aikawa, Masanori; Ashktorab, Hassan; Beckmann, Noam D.; Enger, Michael L.; Espinosa, Joaquin M.; Gai, Xiaowu; Horne, Benjamin D.; Keim...

Initiating Long Covid RECOVERy Jeanne Marrazzo; Gary H. Gibbons; Walter Koroshetz The NIH’s RECOVER Initiative aims to ease the suffering of those living with Long Covid. Link | PDF (Science Translational Medicine) [Open Access]

Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort 60 authors ; on behalf of the RECOVER-Adult Cohort BACKGROUND There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2...

Post–Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2 After Infection During Pregnancy Metz, Torri D.; Reeder, Harrison T.; Clifton, Rebecca G.; Flaherman, Valerie; Aragon, Leyna V.; Baucom, Leah Castro; Beamon, Carmen J.; Braverman, Alexis; Brown, Jeanette; Cao...

Long-term Effects of COVID-19 on the Cardiopulmonary System in Adults and Children: Current Status and Questions to be Resolved by the NIH RECOVER Initiative Franz Rischard; Natasha Altman; Jacqueline Szmuszkovicz; Frank Sciurba; Erika Berman-Rosenzweig; Simon Lee; Sankaran Krishnan; Ngan...

WebMD: Researchers Hunt Biomarkers – Potential Keys to Long COVID https://www.webmd.com/covid/news/20230106/researchers-hunt-long-covid-biomarkers Brief mention of ME/CFS:

There is a petition—looks like all nationalities can sign. Treatments include CBT, exercise.

New thread created by collecting posts from a number of other threads If someone's in a listening mood, there's no transcript. 30 minutes with the NIH Recover initiative lead: Direct link: https://www.nejm.org/action/showMediaPlayer?doi=10.1056/NEJMdo006435&aid=10.1056/NEJMe2201619&area=.

ME/CFS and Long COVID: Q&A With the CDC's Dr Jennifer Cope https://www.medscape.com/viewarticle/984122

The RECOVER Initiative is doing a trial on Paxlovid for long Covid. Here's the listing on ClinicalTrials.gov: SARS CoV-2 Viral Persistence Study (PASC) - Study of Long COVID-19 (PASC) Highlights: Double-blind multi-center trial in the US 1700 participants They'll take the drug for 15 days...

A thread for general NIH news and discussion See also: USA: NIH funding for ME/CFS research Medpage today: "NIH Striving to Avoid False Hope in Chronic Fatigue" Shame about the title, yet again. https://www.medpagetoday.com/publichealthpolicy/publichealth/70529